Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Clinical trial NCT05827081 · RECRUITING

Trial details

NCT number: NCT05827081
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Early Breast Cancer

Start date: 2024-02-28
Primary completion: 2029-09-07
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.